Funnily, or somehow unfortunately, I was talking with a fellow investor about exactly this point yesterday. He asked me if I had talked to the company about the minimum revenue base for each year, which I had on a fair few occasions.
To cut a long story short the crux of the conversations and answers to my many Q's are that both OrbiMed and Unilife are very comfortable with where the company is at, with what's coming up including deal flow, and that meeting the targets talked about is of no concern at all. I'm also under the impression that once we see some of these deals come through we will all have a lot of questions answered as to the company's cash position going forward (including expansion costs, outgoings etc) and why the above minimum revenue base targets are of no concern at all.
Good old Stone Street planting the seed of doubt once again, I wonder if his mates at Kerrisdale have paid him for this........
UNS Price at posting:
44.0¢ Sentiment: Buy Disclosure: Held
